Lipitor vs Symbicort: side-by-side comparison
Lipitor (Cardiovascular Medications) and Symbicort (Respiratory Medications) belong to different therapeutic classes and are rarely interchangeable. This page compares the medications' purposes, mechanisms and the situations where each is used.
| Property | Lipitor | Symbicort |
|---|---|---|
| Active ingredient | Atorvastatin | Budesonide, Formoterol |
| Manufacturer | Pfizer | AstraZeneca |
| Class | Cardiovascular Medications | Respiratory Medications |
| Strengths | 10mg, 20mg, 40mg, 80mg | 80/4.5 mcg, 160/4.5 mcg, 200/6 mcg, 400/12 mcg |
| Forms | tablet | dry powder inhaler, metered-dose inhaler |
What's the same
Lipitor and Symbicort are used in very different patients, and the points in common are limited. The main shared element is that both meet regulatory standards for efficacy and safety and benefit from pharmacist oversight.
Key differences
Lipitor belongs to Cardiovascular Medications while Symbicort belongs to Respiratory Medications. Indications, mechanisms and target populations differ. The comparison is most useful when a clinician has mentioned both medications and the patient wants to understand where each fits.
Mechanism and action
Lipitor: Atorvastatin competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis. Symbicort: Budesonide reduces chronic airway inflammation through glucocorticoid receptor activation, decreasing inflammatory cell recruitment and cytokine release.
When Lipitor is preferred
Lipitor is approved in adults for the treatment of primary hypercholesterolaemia and mixed dyslipidaemia, for the prevention of cardiovascular events in patients at elevated risk and for the secondary prevention of cardiovascular events after acute coronary syndrome, stroke or re…
When Symbicort is preferred
Symbicort is approved in adults and adolescents from age 12 (younger in some markets) for the regular treatment of asthma when combination therapy of a long-acting beta-2 agonist and an inhaled corticosteroid is appropriate, and in some markets for symptom relief in COPD.
Frequently asked questions
Is Lipitor or Symbicort better? ▾
Lipitor and Symbicort are not interchangeable — they treat different conditions. Asking which is "better" is meaningful only when a clinician has weighed both for the same specific clinical scenario.
Can I switch from Lipitor to Symbicort? ▾
Switching between Lipitor and Symbicort is rarely an appropriate decision since they belong to different classes and treat different conditions. The real question is usually whether the diagnosis calls for one medication or the other — which the prescriber resolves.
Do Lipitor and Symbicort have the same side effects? ▾
No — they belong to different classes and have distinct side-effect profiles. Each medication has its own prescribing information.
More Lipitor comparisons
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.